Publication | Closed Access

Treatment with pentylenetetrazole (PTZ) and 4-aminopyridine (4-AP) differently affects survival, locomotor activity, and biochemical markers in Drosophila melanogaster

BiologyDrosophila MelanogasterBiochemical MarkersExperimental BiologyMedicineNeuropharmacologyLocomotor ActivityPharmacology